top of page
presents
image.png

Empowered Relief

Empowered Relief® is an evidence-based, single-session pain class that rapidly equips patients with pain management skills. Developed at Stanford University and presented by Logan University.

Overview

Overview

In a single, 2-hour session , patients and family members are equipped with effective pain relief skills. This class is offered completely free of charge.

We know that pain is often treated as a biomedical problem, or an isolated symptom, rather than as a sensory and emotional experience. Empowered relief classes allow those with chronic pain to suffer less, live better and do more of what's meaningful to them.

Primary Outcomes

Empowered Relief was similar to 8-session CBT for improving:

  • Pain intensity

  • Pain interference

  • Pain catastrophizing

Secondary Outcomes

  • Pain self-efficacy

  • Pain bothersomeness

  • Sleep disturbance

  • Depression

  • Anxiety

  • Fatigue

No upcoming events at the moment

These classes are completely free to participants. Additionally, we know that transportation issues can significantly impact a person's ability to access care and participate in in-person events. Transportation assistance can be provided for those who need additional support.

Upcoming Classes

The Evidence

Empowered Relief® was developed by Beth Darnall, PhD, and has been embedded into clinical pathways at Stanford University since 2013. Early positive scientific results led to major NIH funding to further study the benefits and mechanisms of the single-session pain relief class. In August 2021, JAMA Network Open published results for the NIH-funded randomized trial conducted in adults with chronic low back pain (read the full scientific report here). Findings suggest that the single-session class conferred broad and clinically meaningful benefits across multiple outcomes at 3 months post-treatment (pain intensity, pain interference, pain catastrophizing, pain bothersomeness, anxiety, depression, sleep disturbance, and fatigue). Pragmatic comparative effectiveness studies are planned for 2022.

image.png
image.png
image_edited.jpg
research stock image.png
Evidence
bottom of page